Sponsors

The primary funding for HepCure comes from the New York State Health Foundation and the New York State Department of Health AIDS Institute, with additional support from Merck Foundation, Boehringer Ingelhiim Pharmaceuticals, Inc., Gilead Sciences, Inc., and Bristol-Myers Squibb.